Literature DB >> 25496968

Polarization of macrophages induced by Toxoplasma gondii and its impact on abnormal pregnancy in rats.

Lanting Kong1, Qian Zhang1, Jing Chao2, Huiqin Wen1, Yihua Zhang1, He Chen1, Faustina Pappoe1, Aimei Zhang3, Xiucai Xu3, Yihong Cai1, Min Li1, Qingli Luo1, Linjie Zhang4, Jilong Shen5.   

Abstract

Toxoplasma gondii infection is the leading cause of fetal intrauterine growth retardation among the five kinds of pathogens termed as TORCH, including Toxoplasma, Rubella virus, Cytomegalo virus, herpes virus and others during pregnancy. Pathogens infect the fetus through the placenta. T. gondii infection may result in congenital toxoplasmosis, miscarriage, stillbirth, and preemie, and increase pregnancy complications. Adaptive immune response induced by T. gondii infection stimulates T cells and macrophages to produce high levels of cytokines. Physiologically, the microenvironment of pregnancy was Th2-dominant. Here we set up a pregnant Sprague-Dawley rat model, and reported the polarization of macrophages induced by genotype Chinese 1 strain (Wh6) of Toxoplasma, and its adverse impact on pregnancy. The results showed that Wh6 infection pre- or in-gestation both led to abnormal pregnancy outcomes. Peritoneal macrophages in pre-gestation infection were polarized toward classically activated macrophages (M1), while in-gestation infection drove macrophages to polarize toward M2 activation. The Th2-dominant immune response in pregnant rat somewhat inhibits the excessive bias of the macrophages toward M1, and partially, toward M2. Infection of pre- and in-gestation may alter the physiological immune microenvironment in pregnant rats, giving rise to abnormal pregnancy outcomes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abnormal pregnancy; Macrophage polarization; Rat; Toxoplasma gondii

Mesh:

Substances:

Year:  2014        PMID: 25496968     DOI: 10.1016/j.actatropica.2014.12.001

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Polarisation of human macrophages towards an M1 subtype triggered by an atypical Brazilian strain of Toxoplasma gondii results in a reduction in parasite burden.

Authors:  Paula Suellen Guimaraes Gois; Priscila Silva Franco; Samuel Cota Teixeira; Pamela Mendonca Guirelli; Thadia Evelyn de Araujo; Deivid William da Fonseca Batistao; Fernanda Chaves de Oliveira; Gabriela Licia Santos Ferreira; Angelica de Oliveira Gomes; Silvio Favoreto; Jose Roberto Mineo; Bellisa de Freitas Barbosa; Eloisa Amalia Vieira Ferro
Journal:  Folia Parasitol (Praha)       Date:  2022-10-04       Impact factor: 1.614

2.  Identification of a TNF-α inducer MIC3 originating from the microneme of non-cystogenic, virulent Toxoplasma gondii.

Authors:  Jingfan Qiu; Lijuan Wang; Rong Zhang; Ke Ge; Hongfei Guo; Xinjian Liu; Jinfeng Liu; Delong Kong; Yong Wang
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 3.  Modulators of the Balance between M1 and M2 Macrophages during Pregnancy.

Authors:  Yong-Hong Zhang; Ming He; Yan Wang; Ai-Hua Liao
Journal:  Front Immunol       Date:  2017-02-09       Impact factor: 7.561

4.  Functional aspects, phenotypic heterogeneity, and tissue immune response of macrophages in infectious diseases.

Authors:  Jorge Rodrigues de Sousa; Pedro Fernando Da Costa Vasconcelos; Juarez Antonio Simões Quaresma
Journal:  Infect Drug Resist       Date:  2019-08-22       Impact factor: 4.003

5.  The Role of TSC1 in the Macrophages Against Vibrio vulnificus Infection.

Authors:  Xian-Hui Huang; Yao Ma; Han Lou; Na Chen; Ting Zhang; Liu-Ying Wu; Yi-Ju Chen; Meng-Meng Zheng; Yong-Liang Lou; Dan-Li Xie
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

6.  Decidual Macrophage Functional Polarization during Abnormal Pregnancy due to Toxoplasma gondii: Role for LILRB4.

Authors:  Zhidan Li; Mingdong Zhao; Teng Li; Jing Zheng; Xianbing Liu; Yuzhu Jiang; Haixia Zhang; Xuemei Hu
Journal:  Front Immunol       Date:  2017-08-24       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.